BSE filing, NSE: SBILIFE. Summary written from the filing by ALFA Finder's alert engine.
SBI Life Insurance Company Ltd: key numbers
- Share price
- ₹1,666.70
- Market cap
- ₹1,67,238 Cr
- Revenue (annual)
- ₹1,12,315 Cr
- Net profit (annual)
- ₹2,470 Cr
- P/E (TTM)
- 63.0×Sector 19.7×
- Promoter holding
- 55.31%-0.01% QoQ
- FII holding
- 20.68%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SBI Life Insurance Company Ltd
All →SBI Life Insurance Company Earnings Call Transcript: Key Takeaways
SBI Life delivered a strong 19% growth in Value of New Business (VNB) and margin expansion, effectively managing a one-time ₹530 Cr GST impact while maintaining market leadership.
- Call
- Guides 14% growth
SBI Life Insurance Company Results Update
SBI Life's H1 FY27 profit after tax rose 17% to ₹12.7 billion. Gross written premium grew 13% and the solvency ratio is 1.97.
SBI Life Insurance Company Q2 FY27 Results: Net Profit ₹549.2 Cr, Up 11.0% YoY
SBI Life Insurance Company Ltd reported revenue from operations of ₹26,878 Cr (+8.2% YoY) and net profit of ₹549.2 Cr (+11.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹549.2 Cr · +11.0% YoY
SBI Life Insurance Company Employee Stock Options
SBI Life Insurance has allotted 4,160 equity shares following the exercise of vested employee stock options under its 2018 scheme.
SBI Life Insurance Company Legal & Regulatory
SBI Life Insurance received a tax demand order of ₹1.13 Crore from the Rajasthan GST authority. The company intends to appeal against this order.
- Value
- ₹1.13 Cr
SBI Life Insurance Company Management Change
SBI Life appointed Mr. Nihar Niranjan Jambusaria as an Additional Independent Director for a three-year term effective September 22, 2026.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.